{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:01Z","timestamp":1786982461820,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170087"],"award-info":[{"award-number":["82170087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation of China","award":["L232125"],"award-info":[{"award-number":["L232125"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12602-025-10543-0","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:00:48Z","timestamp":1745913648000},"page":"681-693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics and Antibacterial Activity of Staphylococcus aureus Phage-Derived Endolysin LysP4"],"prefix":"10.1007","volume":"18","author":[{"given":"Mingming","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"12","key":"10543_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/jcm.01006-19","volume":"57","author":"A \u00c1lvarez","year":"2019","unstructured":"\u00c1lvarez A, Fern\u00e1ndez L, Guti\u00e9rrez D, Iglesias B, Rodr\u00edguez A, Garc\u00eda P (2019) Methicillin-resistant Staphylococcus aureus in hospitals: latest trends and treatments based on bacteriophages. J Clin Microbiol 57(12):10\u20131128. https:\/\/doi.org\/10.1128\/jcm.01006-19","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10543_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00209-20","volume":"11","author":"C R\u00f6hrig","year":"2020","unstructured":"R\u00f6hrig C, Huemer M, Lorg\u00e9 D, Luterbacher S, Phothaworn P, Schefer C, Sobieraj AM, Zinsli LV, MairpadyShambat S, Leimer N, Keller AP, Eichenseher F, Shen Y, Korbsrisate S, Zinkernagel AS, Loessner MJ, Schmelcher M (2020) Targeting hidden pathogens: cell-penetrating enzybiotics eradicate intracellular drug-resistant Staphylococcus aureus. mBio 11(2):10\u20131128. https:\/\/doi.org\/10.1128\/mBio.00209-20","journal-title":"mBio"},{"issue":"4","key":"10543_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"NA Turner","year":"2019","unstructured":"Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, Holland TL, Fowler VG Jr (2019) Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol 17(4):203\u2013218. https:\/\/doi.org\/10.1038\/s41579-018-0147-4","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10543_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.01923-17","volume":"9","author":"D Guti\u00e9rrez","year":"2018","unstructured":"Guti\u00e9rrez D, Fern\u00e1ndez L, Rodr\u00edguez A, Garc\u00eda P (2018) Are phage lytic proteins the secret weapon to kill Staphylococcus aureus? mBio 9(1):10\u20131128. https:\/\/doi.org\/10.1128\/mBio.01923-17","journal-title":"mBio"},{"issue":"9","key":"10543_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers HF, Deleo FR (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7(9):629\u2013641. https:\/\/doi.org\/10.1038\/nrmicro2200","journal-title":"Nat Rev Microbiol"},{"key":"10543_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-0711-6-13","volume":"6","author":"HM Neoh","year":"2007","unstructured":"Neoh HM, Hori S, Komatsu M, Oguri T, Takeuchi F, Cui L, Hiramatsu K (2007) Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. Ann Clin Microbiol Antimicrob 6:13. https:\/\/doi.org\/10.1186\/1476-0711-6-13","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10543_CR7","doi-asserted-by":"publisher","unstructured":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis (2022). Lancet (London, England) 399 (10325):629-655.\nhttps:\/\/doi.org\/10.1016\/s0140-6736(21)02724-0","DOI":"10.1016\/s0140-6736(21)02724-0"},{"issue":"3","key":"10543_CR8","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak JR, Talan DA, Chambers HF (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52(3):e18-55. https:\/\/doi.org\/10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10543_CR9","doi-asserted-by":"publisher","first-page":"dlaa114","DOI":"10.1093\/jacamr\/dlaa114","volume":"3","author":"NM Brown","year":"2021","unstructured":"Brown NM, Goodman AL, Horner C, Jenkins A, Brown EM (2021) Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. JAC-Antimicrob Resist 3(1):dlaa114. https:\/\/doi.org\/10.1093\/jacamr\/dlaa114","journal-title":"JAC-Antimicrob Resist"},{"issue":"7","key":"10543_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and global health 109(7):309\u2013318. https:\/\/doi.org\/10.1179\/2047773215y.0000000030","journal-title":"Pathogens and global health"},{"issue":"8","key":"10543_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/v10080396","volume":"10","author":"S Fernandes","year":"2018","unstructured":"Fernandes S, S\u00e3o-Jos\u00e9 C (2018) Enzymes and mechanisms employed by tailed bacteriophages to breach the bacterial cell barriers. Viruses 10(8):396. https:\/\/doi.org\/10.3390\/v10080396","journal-title":"Viruses"},{"key":"10543_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/bs.aivir.2018.09.003","volume":"103","author":"J Cahill","year":"2019","unstructured":"Cahill J, Young R (2019) Phage lysis: multiple genes for multiple barriers. Adv Virus Res 103:33\u201370. https:\/\/doi.org\/10.1016\/bs.aivir.2018.09.003","journal-title":"Adv Virus Res"},{"issue":"2","key":"10543_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/antibiotics10020131","volume":"10","author":"C Kranjec","year":"2021","unstructured":"Kranjec C, Morales Angeles D, TorrissenM\u00e5rli M, Fern\u00e1ndez L, Garc\u00eda P, Kjos M, Diep DB (2021) Staphylococcal biofilms: challenges and novel therapeutic perspectives. Antibiotics (Basel, Switzerland) 10(2):131. https:\/\/doi.org\/10.3390\/antibiotics10020131","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"3","key":"10543_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/mmi.13634","volume":"104","author":"DE Moormeier","year":"2017","unstructured":"Moormeier DE, Bayles KW (2017) Staphylococcus aureus biofilm: a complex developmental organism. Mol Microbiol 104(3):365\u2013376. https:\/\/doi.org\/10.1111\/mmi.13634","journal-title":"Mol Microbiol"},{"issue":"9276","key":"10543_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/s0140-6736(01)05321-1","volume":"358","author":"PS Stewart","year":"2001","unstructured":"Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet (London, England) 358(9276):135\u2013138. https:\/\/doi.org\/10.1016\/s0140-6736(01)05321-1","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10543_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4248\/ijos11026","volume":"3","author":"N H\u00f8iby","year":"2011","unstructured":"H\u00f8iby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen P, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3(2):55\u201365. https:\/\/doi.org\/10.4248\/ijos11026","journal-title":"Int J Oral Sci"},{"key":"10543_CR17","doi-asserted-by":"publisher","first-page":"625341","DOI":"10.1155\/2013\/625341","volume":"2013","author":"M Fenton","year":"2013","unstructured":"Fenton M, Keary R, McAuliffe O, Ross RP, O\u2019Mahony J, Coffey A (2013) Bacteriophage-derived peptidase CHAP(K) eliminates and prevents staphylococcal biofilms. Int J Microbiol 2013:625341. https:\/\/doi.org\/10.1155\/2013\/625341","journal-title":"Int J Microbiol"},{"issue":"2","key":"10543_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijantimicag.2012.10.011","volume":"41","author":"SY Jun","year":"2013","unstructured":"Jun SY, Jung GM, Yoon SJ, Oh MD, Choi YJ, Lee WJ, Kong JC, Seol JG, Kang SH (2013) Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1. Int J Antimicrob Agents 41(2):156\u2013161. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.10.011","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10543_CR19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00253-009-2386-9","volume":"86","author":"JS Son","year":"2010","unstructured":"Son JS, Lee SJ, Jun SY, Yoon SJ, Kang SH, Paik HR, Kang JO, Choi YJ (2010) Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. Appl Microbiol Biotechnol 86(5):1439\u20131449. https:\/\/doi.org\/10.1007\/s00253-009-2386-9","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"10543_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1128\/aem.01616-06","volume":"73","author":"P Sass","year":"2007","unstructured":"Sass P, Bierbaum G (2007) Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol 73(1):347\u2013352. https:\/\/doi.org\/10.1128\/aem.01616-06","journal-title":"Appl Environ Microbiol"},{"issue":"9","key":"10543_CR21","doi-asserted-by":"publisher","first-page":"e107307","DOI":"10.1371\/journal.pone.0107307","volume":"9","author":"D Guti\u00e9rrez","year":"2014","unstructured":"Guti\u00e9rrez D, Ruas-Madiedo P, Mart\u00ednez B, Rodr\u00edguez A, Garc\u00eda P (2014) Effective removal of staphylococcal biofilms by the endolysin LysH5. PLoS ONE 9(9):e107307. https:\/\/doi.org\/10.1371\/journal.pone.0107307","journal-title":"PLoS ONE"},{"issue":"15","key":"10543_CR22","doi-asserted-by":"publisher","first-page":"e00886","DOI":"10.1128\/aem.00886-18","volume":"84","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Cheng M, Zhang H, Dai J, Guo Z, Li X, Ji Y, Cai R, Xi H, Wang X, Xue Y, Sun C, Feng X, Lei L, Han W, Gu J (2018) Antibacterial effects of phage lysin LysGH15 on planktonic cells and biofilms of diverse staphylococci. Appl Environ Microbiol 84(15):e00886-18. https:\/\/doi.org\/10.1128\/aem.00886-18","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"10543_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.16016\/j.1000-5404.201909016","volume":"42","author":"M Gao","year":"2020","unstructured":"Gao M, Liu H, Li P, Zhang Z, Qin Y, Huang Y, Cui Y, Pe IG, Tong Y, Bai C (2020) Isolation and complete genome analysis of Staphylococcus aureus bacteriophage vB_SauH_IME522. J Third Mil Med Univ 42(3):229\u2013240. https:\/\/doi.org\/10.16016\/j.1000-5404.201909016","journal-title":"J Third Mil Med Univ"},{"key":"10543_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fcimb.2017.00290","volume":"7","author":"H Haddad Kashani","year":"2017","unstructured":"Haddad Kashani H, Fahimi H, Dasteh Goli Y, Moniri R (2017) A novel chimeric endolysin with antibacterial activity against methicillin-resistant Staphylococcus aureus. Front Cell Infect Microbiol 7:290. https:\/\/doi.org\/10.3389\/fcimb.2017.00290","journal-title":"Front Cell Infect Microbiol"},{"key":"10543_CR25","doi-asserted-by":"publisher","first-page":"668430","DOI":"10.3389\/fcimb.2021.668430","volume":"11","author":"Y Lu","year":"2021","unstructured":"Lu Y, Wang Y, Wang J, Zhao Y, Zhong Q, Li G, Fu Z, Lu S (2021) Phage endolysin LysP108 showed promising antibacterial potential against methicillin-resistant Staphylococcus aureus. Front Cell Infect Microbiol 11:668430. https:\/\/doi.org\/10.3389\/fcimb.2021.668430","journal-title":"Front Cell Infect Microbiol"},{"key":"10543_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2180-12-33","volume":"12","author":"B Son","year":"2012","unstructured":"Son B, Yun J, Lim JA, Shin H, Heu S, Ryu S (2012) Characterization of LysB4, an endolysin from the Bacillus cereus-infecting bacteriophage B4. BMC Microbiol 12:33. https:\/\/doi.org\/10.1186\/1471-2180-12-33","journal-title":"BMC Microbiol"},{"issue":"7","key":"10543_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.00024-19","volume":"63","author":"A Raz","year":"2019","unstructured":"Raz A, Serrano A, Hernandez A, Euler CW, Fischetti VA (2019) Isolation of phage lysins that effectively kill Pseudomonas aeruginosa in mouse models of lung and skin infection. Antimicrob Agents Chemother 63(7):10\u20131128. https:\/\/doi.org\/10.1128\/aac.00024-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10543_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/jvi.01163-18","volume":"93","author":"H Oliveira","year":"2019","unstructured":"Oliveira H, Costa AR, Ferreira A, Konstantinides N, Santos SB, Boon M, Noben JP, Lavigne R, Azeredo J (2019) Functional analysis and antivirulence properties of a new depolymerase from a myovirus that infects Acinetobacter baumannii capsule K45. J Virol 93(4):10\u20131128. https:\/\/doi.org\/10.1128\/jvi.01163-18","journal-title":"J Virol"},{"key":"10543_CR29","doi-asserted-by":"publisher","unstructured":"Synergism Testing: Broth Microdilution Checkerboard and Broth Macrodilution Methods (2016). In: Clinical microbiology procedures handbook. pp 5.16.11\u201315.16.23. https:\/\/doi.org\/10.1128\/9781555818814.ch5.16","DOI":"10.1128\/9781555818814.ch5.16"},{"issue":"2","key":"10543_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","volume":"6","author":"M Balouiri","year":"2016","unstructured":"Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 6(2):71\u201379. https:\/\/doi.org\/10.1016\/j.jpha.2015.11.005","journal-title":"J Pharm Anal"},{"issue":"9","key":"10543_CR31","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/infdis\/jit637","volume":"209","author":"R Schuch","year":"2014","unstructured":"Schuch R, Lee HM, Schneider BC, Sauve KL, Law C, Khan BK, Rotolo JA, Horiuchi Y, Couto DE, Raz A, Fischetti VA, Huang DB, Nowinski RC, Wittekind M (2014) Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia. J Infect Dis 209(9):1469\u20131478. https:\/\/doi.org\/10.1093\/infdis\/jit637","journal-title":"J Infect Dis"},{"issue":"1","key":"10543_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/cmr.00071-17","volume":"31","author":"H Haddad Kashani","year":"2018","unstructured":"Haddad Kashani H, Schmelcher M, Sabzalipoor H, Seyed Hosseini E, Moniri R (2018) Recombinant endolysins as potential therapeutics against antibiotic-resistant Staphylococcus aureus: current status of research and novel delivery strategies. Clin Microbiol Rev 31(1):10\u20131128. https:\/\/doi.org\/10.1128\/cmr.00071-17","journal-title":"Clin Microbiol Rev"},{"issue":"5549","key":"10543_CR33","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1126\/science.1066869","volume":"294","author":"JM Loeffler","year":"2001","unstructured":"Loeffler JM, Nelson D, Fischetti VA (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (New York, NY) 294(5549):2170\u20132172. https:\/\/doi.org\/10.1126\/science.1066869","journal-title":"Science (New York, NY)"},{"issue":"20","key":"10543_CR34","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1128\/jb.187.20.7161-7164.2005","volume":"187","author":"S O'Flaherty","year":"2005","unstructured":"O\u2019Flaherty S, Coffey A, Meaney W, Fitzgerald GF, Ross RP (2005) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187(20):7161\u20137164. https:\/\/doi.org\/10.1128\/jb.187.20.7161-7164.2005","journal-title":"J Bacteriol"},{"issue":"1","key":"10543_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1574-6968.2009.01541.x","volume":"294","author":"SC Becker","year":"2009","unstructured":"Becker SC, Dong S, Baker JR, Foster-Frey J, Pritchard DG, Donovan DM (2009) LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett 294(1):52\u201360. https:\/\/doi.org\/10.1111\/j.1574-6968.2009.01541.x","journal-title":"FEMS Microbiol Lett"},{"issue":"3","key":"10543_CR36","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1128\/aem.01831-08","volume":"75","author":"M Horgan","year":"2009","unstructured":"Horgan M, O\u2019Flynn G, Garry J, Cooney J, Coffey A, Fitzgerald GF, Ross RP, McAuliffe O (2009) Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol 75(3):872\u2013874. https:\/\/doi.org\/10.1128\/aem.01831-08","journal-title":"Appl Environ Microbiol"},{"key":"10543_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-540-75418-3_10","volume":"322","author":"M Otto","year":"2008","unstructured":"Otto M (2008) Staphylococcal biofilms. Curr Top Microbiol Immunol 322:207\u2013228. https:\/\/doi.org\/10.1007\/978-3-540-75418-3_10","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10543_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1128\/aac.47.1.375-377.2003","volume":"47","author":"JM Loeffler","year":"2003","unstructured":"Loeffler JM, Fischetti VA (2003) Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother 47(1):375\u2013377. https:\/\/doi.org\/10.1128\/aac.47.1.375-377.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10543_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1756-0500-5-280","volume":"5","author":"SE George","year":"2012","unstructured":"George SE, Chikkamadaiah R, Durgaiah M, Joshi AA, Thankappan UP, Madhusudhana SN, Sriram B (2012) Biochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128. BMC Res Notes 5:280. https:\/\/doi.org\/10.1186\/1756-0500-5-280","journal-title":"BMC Res Notes"},{"issue":"5","key":"10543_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064671","volume":"8","author":"L Rodr\u00edguez-Rubio","year":"2013","unstructured":"Rodr\u00edguez-Rubio L, Mart\u00ednez B, Rodr\u00edguez A, Donovan DM, G\u00f6tz F, Garc\u00eda P (2013) The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance. PLoS ONE 8(5):e64671. https:\/\/doi.org\/10.1371\/journal.pone.0064671","journal-title":"PLoS ONE"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10543-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10543-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10543-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:30:26Z","timestamp":1773833426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10543-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10543"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10543-0","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"16 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}